Arrowhead Pharmaceuticals Inc (MEX:ARWR)
MXN 586 0 (0%) Market Cap: 51.46 Bil Enterprise Value: 45.09 Bil PE Ratio: 0 PB Ratio: 7.54 GF Score: 51/100

Arrowhead Pharmaceuticals Inc ARO-C3 KOL Webinar Transcript

Oct 26, 2021 / 07:00PM GMT
Release Date Price: MXN1277
Operator

Good afternoon, and welcome to the Arrowhead Pharmaceuticals KOL event. (Operator Instructions) As a reminder, this event is being recorded, and a replay will be made available on the Arrowhead Pharmaceuticals website following the conclusion of the formal presentation.

I would now like to turn the call over to Vince Anzalone, Vice President of Investor Relations at Arrowhead. Please go ahead, Vince.

Vincent Anzalone
Arrowhead Pharmaceuticals, Inc. - VP of IR

Thank you, Sarah, and thanks, everybody, for joining us today. Go ahead and click forward, please. So just to remind you all, we will be making forward-looking statements on today's call. So please refer to our SEC filings for risk factors.

Next slide, please. So we've got a really good event today. We've got a great panel from external. Outside of the company, we have Dr. Richard Glassock, from the David Geffen School of Medicine at UCLA. And we also have Dr. Peter Browett, from the University of Auckland School of Medicine.

From the company, we have our Senior Vice President

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot